Article

Aziz Nazha Discusses the Future of Treating Patients With MDS

Author(s):

Aziz Nazha

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Related Videos
Image of man with black hair.
Image of a man with dark hair and some facial hair.
Image of a man with blond facial hair.
Image of woman with blonde hair.
Image of a woman with long red hair.
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Image of a man with short black hair.
Related Content
Patients with relapsed or refractory MDS may experience improved overall survival with , depending on certain prognostic factors.
November 20th 2024

Donor Lymphocyte Infusion May Improve Survival in R/R MDS

Ashley Chan
Patients with relapsed or refractory MDS may experience improved overall survival with DLI, depending on certain prognostic factors.
Illustration of woman with blonde hair.
November 20th 2024

What Patients with Breast Cancer Need to Know About Lymphedema Risk

Alex Biese
CURE® spoke with a physical therapist specializing in oncology to find out more about this condition some patients with cancer are at risk for.
Image of woman with brown hair.
November 19th 2024

Newer Therapies for Acute Lymphoblastic Leukemia May Reduce Side Effects

Spencer Feldman Darlene Dobkowski, MA
New treatments for acute lymphoblastic leukemia may lead to fewer side effects than chemotherapy, as they target cancer cells more precisely, an expert said.
Illustration of blood cells.
November 19th 2024

Venclexta Regimen Beneficial for Patients with AML and MDS

Alex Biese
Researchers have found an overall survival benefit and manageable safety profile with Venclexta for patients with AML and MDS.
Image of a woman with short blonde hair, wearing a colorful striped shirt.
November 19th 2024

Why Clinical Trials Don’t Have to Be Patients’ ‘Last Line of Defense’

Alex Biese
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients with cancer to enroll.
Image of red blood cells.
November 18th 2024

Trial for Patients With High-Risk MDS Misses Goal, Discontinues Study

Ashley Chan
A trial evaluating the tamibarotene-Vidaza combination in certain patients with newly diagnosed high-risk MDS will be discontinued.